[1] |
CSCO黑色素瘤专家委员会. 中国黑色素瘤诊治指南(2015版)[M]. 北京: 人民卫生出版社, 2015, 40⁃41.
|
[2] |
Olszanski AJ. Current and future roles of targeted therapy and immunotherapy in advanced melanoma[J]. J Manag Care Spec Pharm, 2014, 20(4): 346⁃356. DOI: 10.18553/jmcp.2014.20.4. 346.
|
[3] |
Otáhal P, Trněn M. Current approaches in cancer immuno⁃therapy[J]. Klin Onkol, 2015, 28 Suppl 3: 3S105⁃111. DOI: 10.14735/amko20153S105. PMID: 26489509.
|
[4] |
钱其军, 吴孟超. 肿瘤精准细胞免疫治疗: 梦想照进现实[J]. 中国肿瘤生物治疗杂志, 2015, 22(2): 151⁃158. DOI: 10.3872/j.issn.1007⁃385X.2015.02.003.
|
[5] |
Huang X, Cui S, Shu Y. Cisplatin selectively downregulated the frequency and immunoinhibitory function of myeloid⁃derived suppressor cells in a murine B16 melanoma model[J]. Immunol Res, 2016, 64(1): 160⁃170. DOI: 10.1007/s12026⁃015⁃8734⁃1.
|
[6] |
张家模, 吴小候, 张翾, 等. 白细胞介素2锚定的exosomes的制备及其对膀胱癌细胞的诱导杀伤效应[J]. 中华肿瘤杂志, 2011, 33(8): 564⁃569. DOI: 10.3760/cma.j.issn.0253⁃3766.2011. 08.002.
|
[7] |
李安娜. IL⁃2基因转染的CIK细胞联合树突状细胞的抗肝癌实验研究[D]. 南宁: 广西医科大学, 2008.
|
[8] |
张蕾, 李芳秋, 张士新, 等. LDH释放法检测肿瘤患者PBMC和CIK细胞的细胞毒活性[J]. 现代检验医学杂志, 2008, 23(6): 27⁃29. DOI: 10.3969/j.issn.1671⁃7414.2008.06.008.
|
[9] |
钱悦, 蒋苹, 褚淑娟, 等. 携带MIA基因单核细胞增生性李斯特菌抑制恶性黑素瘤的研究[J]. 中华皮肤科杂志, 2009, 42(6): 399⁃401. DOI: 10.3760/cma.j.issn.0412⁃4030.2009.06.011.
|
[10] |
Carmenate T, Pacios A, Enamorado M, et al. Human IL⁃2 mutein with higher antitumor efficacy than wild type IL⁃2[J]. J Immunol, 2013, 190(12): 6230⁃6238. DOI: 10.4049/jimmunol.1201895.
|
[11] |
Vacca P, Martini S, Garelli V, et al. NK cells from malignant pleural effusions are not anergic but produce cytokines and display strong antitumor activity on short⁃term IL⁃2 activation[J]. Eur J Immunol, 2013, 43(2): 550⁃561. DOI: 10.1002/eji.201242783.
|
[12] |
Hughes T, Klairmont M, Broucek J, et al. The prognostic significance of stable disease following high⁃dose interleukin⁃2 (IL⁃2) treatment in patients with metastatic melanoma and renal cell carcinoma[J]. Cancer Immunol Immunother, 2015, 64(4): 459⁃465. DOI: 10.1007/s00262⁃014⁃1652⁃6.
|
[13] |
刘秋霞. 真核表达载体P EGFP⁃N1⁃IL⁃2构建及CIK细胞的体外扩增[D]. 承德: 承德医学院, 2007.
|
[14] |
Rossowska J, Pajtasz⁃Piasecka E, Rysnik O, et al. Generation of antitumor response by IL⁃2⁃transduced JAWS II dendritic cells[J]. Immunobiology, 2011, 216(10): 1074⁃1084. DOI: 10.1016/j.imbio.2011.05.006.
|
[15] |
Guo Y, Han W. Cytokine⁃induced killer (CIK) cells: from basic research to clinical translation[J]. Chin J Cancer, 2015, 34(3): 99⁃107. DOI: 10.1186/s40880⁃015⁃0002⁃1.
|
[16] |
Wang W, Meng M, Zhang Y, et al. Global transcriptome⁃wide analysis of CIK cells identify distinct roles of IL⁃2 and IL⁃15 in acquisition of cytotoxic capacity against tumor[J]. BMC Med Genomics, 2014, 7: 49. DOI: 10.1186/1755⁃8794⁃7⁃49.
|